Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H10O |
| Molecular Weight | 182.2179 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChIKey=RWCCWEUUXYIKHB-UHFFFAOYSA-N
InChI=1S/C13H10O/c14-13(11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H
| Molecular Formula | C13H10O |
| Molecular Weight | 182.2179 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.drugbank.ca/drugs/DB01878Curator's Comment: Description was created using several sources including:
http://apps.who.int/iris/bitstream/10665/42578/1/WHO_TRS_909.pdf; http://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm091048.htm; http://www.fda.gov/downloads/drugs/developmentapprovalprocess/developmentresources/over-the-counterotcdrugs/statusofotcrulemakings/ucm090435.pdf; https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a68508b-f1fa-4f03-b28a-554e24cf58d6; https://clinicaltrials.gov/ct2/show/NCT01695356?term=BENZOPHENONE&rank=1; https://clinicaltrials.gov/ct2/show/NCT01695356?term=BENZOPHENONE&rank=1; https://www.ncbi.nlm.nih.gov/pubmed/26753716
Sources: http://www.drugbank.ca/drugs/DB01878
Curator's Comment: Description was created using several sources including:
http://apps.who.int/iris/bitstream/10665/42578/1/WHO_TRS_909.pdf; http://www.fda.gov/food/ingredientspackaginglabeling/foodadditivesingredients/ucm091048.htm; http://www.fda.gov/downloads/drugs/developmentapprovalprocess/developmentresources/over-the-counterotcdrugs/statusofotcrulemakings/ucm090435.pdf; https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a68508b-f1fa-4f03-b28a-554e24cf58d6; https://clinicaltrials.gov/ct2/show/NCT01695356?term=BENZOPHENONE&rank=1; https://clinicaltrials.gov/ct2/show/NCT01695356?term=BENZOPHENONE&rank=1; https://www.ncbi.nlm.nih.gov/pubmed/26753716
Benzophenone is the organic compound. It is a flavouring agent evaluated as safe at current levels of intake by joint FAO/WHO Expert Committee on Food Additives (JECFA) and approved by FDA as a food additive and as UV protector. Substituted benzophenones such as oxybenzone (benzophenone-3) and dioxybenzone are used in sunscreens in cosmetics and as a sunscreen ingredients in some topical drugs in combination with skin lighteners for gradual fading of dark (brownish) areas in the skin such as freckles, age and liver spots or treatment of melanosis. Benzophenone derivatives can be used as a photo initiators. Benzophenone used in practical synthesis of some drugs.
Originator
Sources: http://www.orgsyn.org/demo.aspx?prep=cv1p0095
Curator's Comment: C. S. Marvel and W. M. Sperry described the synthesis of benzothenone in 1928
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Biochemical and structural studies with prenyl diphosphate analogues provide insights into isoprenoid recognition by protein farnesyl transferase. | 2003-04-08 |
|
| Catalytic asymmetric Mannich reactions of glycine derivatives with imines. A new approach to optically active alpha,beta-diamino acid derivatives. | 2003-04-04 |
|
| Diazotrifluoropropionamido-containing prenylcysteines: syntheses and applications for studying isoprenoid-protein interactions. | 2003-03-06 |
|
| Cryptophycin affinity labels: synthesis and biological activity of a benzophenone analogue of cryptophycin-24. | 2003-02-24 |
|
| Determination of benzophenones in a cosmetic matrix by supercritical fluid extraction and capillary electrophoresis. | 2003-02-14 |
|
| Structure-activity relationships of novel anti-malarial agents: part 5. N-(4-acylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides. | 2003-02-10 |
|
| Three-fold interpenetrating three-dimensional networks based on C-methylcalix[4]resorcinarene incorporating benzophenone guest molecules. | 2003-02-07 |
|
| Unexpected differences in the alpha-halogenation and related reactivity of sulfones with perhaloalkanes in KOH-t-BuOH. | 2003-01-24 |
|
| High-intensity ultrasound-promoted reformatsky reactions. | 2003-01-24 |
|
| Tuning copper-dioxygen reactivity and exogenous substrate oxidations via alterations in ligand electronics. | 2003-01-22 |
|
| New series of N-substituted phenyl ketone oxime ethers: synthesis and bovine beta3-adrenergic agonistic activities. | 2003-01 |
|
| Methionine proximity assay, a novel method for exploring peptide ligand-receptor interaction. | 2002-12-31 |
|
| Migration of surrogate contaminants in paper and paperboard into water through polyethylene coating layer. | 2002-12 |
|
| Benzophenone-induced estrogenic potency in ovariectomized rats. | 2002-12 |
|
| p-Nitrobenzenesulfenate esters as precursors for laser flash photolysis studies of alkyl radicals. | 2002-11-29 |
|
| Molecular structure of the solvated proton in isolated salts. Short, strong, low barrier (SSLB) H-bonds. | 2002-11-20 |
|
| Photoinduced electron transfer cleavage of oxetane adducts of uracil and cytosine. | 2002-09 |
|
| Biotransformation of cyclizine in greyhounds. 2: N(1)-dealkylation and identification of some neutral and phenolic metabolites in canine urine by gas chromatography-mass spectrometry. | 2002-09 |
|
| Modulation of GABA(A) receptor-mediated currents by benzophenone derivatives in isolated rat Purkinje neurones. | 2002-09 |
|
| Identification of the extracellular loop 2 as the point of interaction between the N terminus of the chemokine MIP-1alpha and its CCR1 receptor. | 2002-09 |
|
| Genotoxic activation of benzophenone and its two metabolites by human cytochrome P450s in SOS/umu assay. | 2002-08-26 |
|
| Triplet energy distribution in photoinitiators containing two dissociable groups. | 2002-08-23 |
|
| The development of an improved carrier system for sunscreen formulations based on crystalline lipid nanoparticles. | 2002-08-21 |
|
| 4,4'-Benzophenone-O,O'-disulfamate: a potent inhibitor of steroid sulfatase. | 2002-08-19 |
|
| Oligonucleotides containing 7-vinyl-7-deazaguanine as a facile strategy for expanding the functional diversity of DNA. | 2002-08-05 |
|
| [Determination of alkylphenols, bisphenol A, benzophenone and phthalates in containers of baby food, and migration into food simulants]. | 2002-08 |
|
| New photoactivators for multiphoton excited three-dimensional submicron cross-linking of proteins: bovine serum albumin and type 1 collagen. | 2002-08 |
|
| Hydrogenation without a transition-metal catalyst: on the mechanism of the base-catalyzed hydrogenation of ketones. | 2002-07-24 |
|
| Identification of two tamoxifen target proteins by photolabeling with 4-(2-morpholinoethoxy)benzophenone. | 2002-07-18 |
|
| [Results of a French nationwide survey of cutaneous side effects of ketoprofen gel reported between September 1996 and August 2000]. | 2002-07-02 |
|
| Identification of the principal binding site for RGD-containing ligands in the alpha(V)beta(3) integrin: a photoaffinity cross-linking study. | 2002-07-02 |
|
| Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids. | 2002-07 |
|
| New cytotoxic coumarins and prenylated benzophenone derivatives from the bark of Ochrocarpos punctatus from the Madagascar rainforest. | 2002-07 |
|
| Stability indicating methods for the determination of loratadine in the presence of its degradation product. | 2002-06-15 |
|
| Synthesis and protein kinase inhibitory activity of balanol analogues with modified benzophenone subunits. | 2002-06-06 |
|
| Synthesis and structure-activity relationship of 2-aminobenzophenone derivatives as antimitotic agents. | 2002-06-06 |
|
| Polarographic determination of phenytoin and benzophenone (as impurity) in pharmaceutical preparations. | 2002-05-15 |
|
| [Cross-reaction potentials of ketoprofen]. | 2002-05-12 |
|
| Oxidation of sulfides and disulfides under electron transfer or singlet oxygen photosensitization using soluble or grafted sensitizers. | 2002-05 |
|
| Oxygen transfer from sulfoxides: oxidation of alkylarenes catalyzed by a polyoxomolybdate, [PMo12O40]3-. | 2002-04-24 |
|
| Experimental study on phototoxicity and the photosensitization potential of ketoprofen, suprofen, tiaprofenic acid and benzophenone and the photocross-reactivity in guinea pigs. | 2002-04 |
|
| Complete LC/MS analysis of a Tinnevelli senna pod extract and subsequent isolation and identification of two new benzophenone glucosides. | 2002-04 |
|
| Fate of excited probes in micellar systems. | 2002-03-29 |
|
| Stereoselective intramolecular hydrogen abstraction by a chiral benzophenone derivative. | 2002-02-07 |
|
| Structure-reactivity relationships in the photoreduction of n,pi*-excited ketones and azoalkanes: the effect of reaction thermodynamics, excited-state electrophilicity, and antibonding character in the transition state. | 2002-02 |
|
| Photoimmobilization of biomolecules within a 3-dimensional hydrogel matrix. | 2002 |
|
| Structure based design of benzophenone-based non-thiol farnesyltransferase inhibitors. | 2002 |
|
| The use of a photoactivatable kaempferol analogue to probe the role of flavonol 3-O-galactosyltransferase in pollen germination. | 2002 |
|
| Evaluating the potential for recycling all PET bottles into new food packaging. | 2002 |
|
| Hydrogen abstraction from ionic liquids by benzophenone triplet excited states. | 2001-11-21 |
Patents
Sample Use Guides
Apply a small amount of gel as a thin layer on the affected area twice daily, or use as directed by a doctor (50 g of gel contains 1 g of hydroquinone and 0.05 g benzophenone)
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26753716
The patterned co-culture of different types of living cells in a microfluidic device is crucial for the analysis of cellular interactions and cell-cell communication. Cell patterning was achieved by photocrosslinking 0.2 M benzophenone-4-isocyocyanate in a microfluidic channel. Patterning and co-culture of non-adherent K562 cells and adherent RF-6A cells was achieved by successive rounds of patterning. The present approach is expected to be useful for the development of in vitro methods for studying cell signaling.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:33:01 GMT 2025
by
admin
on
Mon Mar 31 17:33:01 GMT 2025
|
| Record UNII |
701M4TTV9O
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
JECFA EVALUATION |
BENZOPHENONE
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
||
|
CFR |
21 CFR 172.515
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
||
|
EPA PESTICIDE CODE |
315
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID0021961
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
6809
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
1056130
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
119-61-9
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
SUB13019MIG
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
BENZOPHENONE
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
8077
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
3102
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
m2370
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000077159
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
41308
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
701M4TTV9O
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
204-337-6
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
DB01878
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
18997
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | RxNorm | ||
|
C047723
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
701M4TTV9O
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY | |||
|
745
Created by
admin on Mon Mar 31 17:33:01 GMT 2025 , Edited by admin on Mon Mar 31 17:33:01 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY | |||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |